Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long?
Onkologie
; 28(8-9): 391-6, 2005 Aug.
Article
en En
| MEDLINE
| ID: mdl-16160401
ABSTRACT
BACKGROUND:
The risk for patients with primary brain tumors of experiencing an epileptic seizure at least once in the course of disease probably exceeds 50%, depending on tumor location and tumor type. Several aspects regarding the role of anticonvulsants in the treatment of brain tumor patients have remained controversial. PATIENTS ANDMETHODS:
We reviewed the seizure history in 107 patients undergoing a surgical procedure for glioma at our institution.RESULTS:
The overall seizure incidence was 68%. Pre-operative seizures did not predict the occurrence of post-operative seizures. After surgery, postoperative chemo- or radiotherapy and anticonvulsive therapy one third of patients was seizure-free whereas one third showed frequent seizures despite this treatment. Seizure frequency increased regardless of anticonvulsive treatment with progressive or recurrent tumor growth.CONCLUSIONS:
Based on a literature review and our institutional experience, we delineate some recommendations for the management of seizures in patients with brain tumors.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Encefálicas
/
Corteza Cerebral
/
Epilepsias Parciales
/
Glioma
/
Anticonvulsivantes
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Límite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Onkologie
Año:
2005
Tipo del documento:
Article
País de afiliación:
Alemania